Diverticulitis Market Size
Market Size in USD Bn
CAGR7.4%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 7.4% |
| Market Concentration | Medium |
| Major Players | Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Allergan (now part of AbbVie), Bayer AG, Johnson & Johnson, Pfizer Inc. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Diverticulitis Market Analysis
The diverticulitis market is estimated to be valued at USD 2.88 Bn in 2025 and is expected to reach USD 4.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032. The aging population is more prone to develop diverticulitis, as it often occurs in older age groups. This increases the risk of complications associated with the disease.